AIM ImmunoTech
AIM----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: AIM ImmunoTech(AIM) predict that the Revenue is 22 K (+37.5%), Beat estimate;the EBIT is -2.226 M (+38.49%), Beat estimate;the EPS is -0.69 (+86.19%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B37.50%
0.00B100.00%
+0.00B137.50%
EBITExceed expectations
-0.00B38.49%
-0.00B19.87%
+0.00B18.62%
EPSMiss expectations
-0.6986.19%
-0.3792.59%
-0.32006.40%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf